Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 2mg;  ; sirolimus 2mg - coated tablet - 2 mg - active: sirolimus 2mg   excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate ferrous oxide glyceryl mono-oleate iron oxide yellow lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac sucrose titanium dioxide active: sirolimus 2mg excipient: calcium sulfate carnauba wax dl-alpha tocopheryl acetate glyceryl mono-oleate lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose opacode red s-1-15095 poloxamer 188 povidone purified talc shellac sucrose titanium dioxide - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 5mg - coated tablet - 5 mg - active: sirolimus 5mg excipient: calcium sulfate dihydrate carnauba wax ferrous oxide glyceryl mono-oleate ink-red opacode s-1-15038 (e) pharmaceutical glaze iron oxide yellow lactose monohydrate macrogol 20000 macrogol 8000 magnesium stearate microcrystalline cellulose poloxamer 188 povidone purified talc sucrose titanium dioxide - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 1 mg/ml;   - oral solution - 1 mg/ml - active: sirolimus 1 mg/ml   excipient: phosal 50 pg polysorbate 80 - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - concentrate for solution for infusion - tacrolimus 5 mg/ml - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Ισραήλ - Αγγλικά - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.